If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email firstname.lastname@example.org.
Please tell us what format you need. It will help us if you say what assistive technology you use.
This HPA expert working group (now part of PHE) interim guidance provides information on the use of tetanus immunoglobulin for the treatment of tetanus.